Clean Cells
Mission and values
Since our creation, we have always aimed at providing the biopharmaceutical industry with innovative solutions in order to take part in the development of new therapies. Individuals are at the heart of our considerations and our projects; our customers, our providers, our partners and our own team are all given a particular attention. Trust and benevolence are Clean Cells’ core values and we endeavor to apply them in all circumstances. After 18 years working for the enhanced safety of biologics and building our team’s expertise, Clean Cells is now using the momentum to establish itself as a CDMO for innovative therapies.
Our goal remains the same: do our part in patients’ well-being.
Olivier Boisteau, Co-founder at Clean Cells
In the news
See all news
The quarterly scientific journal
Clean Mails
Here is the last edition of our quarterly Clean Mails newsletter, having as main subject: "BSL3 GMP manufacturing suite". To read about this and find out Clean Cells, Naobios and Biodextris’ news or to receive our next editions, click here.
Upstream process optimization of bacteriophage production
using Design of Experiment
Clean Cells’ process development department has worked on implementing a robust and flexible Design of Experiment approach for upstream process optimization leading to higher titers and the characterization of a design space.
Clean Biologics was born in 2018 from a fruitful alliance between Clean Cells and Archimed. Through this partnership, the group soon acquired and integrated CDMO Naobios to extend the service offer and to promote our future-oriented thinking. The expertise, transparency, progress and a human-centred view are at the core of our identity. Day after day, we use our knowledge and our skills to deliver high-quality services in innovative projects with an unwavering dynamism and commitment.